Dynavax Technologies reported $9.68M in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Adma Biologics ADMA:US $ -15581230 416.98K
Agenus AGEN:US $ -66395000 25.02M
Alexion Pharmaceuticals ALXN:US $ 816.7M 185.9M
Amgen AMGN:US $ 2333M 204M
AstraZeneca AZN:LN 1.4B 366M
Astrazeneca AZN:US 1.4B 366M
Biogen BIIB:US $ 1030.1M 12.3M
Biomarin Pharmaceutical BMRN:US $ 13.86M 13.56M
BioSpecifics Technologies BSTC:US 651.19K 676.28K
Bristol Myers Squibb BMY:US $ 2967M 411M
Chimerix CMRX:US -17815000 3.25M
Dynavax Technologies DVAX:US $ 9.68M 19.34M
Gilead Sciences GILD:US $ 2262M 639M
Glaxosmithkline GSK:US 1.96B 281M
Gw Pharmaceuticals GWPH:US -21027000 1.78M
Idera Pharmaceuticals IDRA:US $ -6365000 3.66M
Merk MRK:US $ 3930M 332M
Minerva Neurosciences NERV:US $ -8963290 1.46M
Nektar Therapeutics NKTR:US $ -110205000 813K
Neurocrine Biosciences NBIX:US $ 67.8M 36.3M
Novartis NOVN:VX 3.4B 415M
Pfizer PFE:US $ 6662M 905M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Sarepta Therapeutics SRPT:US $ -167574000 25.71M
Tg Therapeutics TGTX:US $ -77492000 11.71M
Vertex Pharmaceuticals VRTX:US $ -36.36M 920.29M